Fig. S1. Treatment with ENU during adulthood did not lead to tumour formation.

Fig. S2. Cellular contribution to the partial regeneration in the SVZ during the treatment period.

Fig. S3. Quantification of expression level of the p21Cip1/WAF1 gene.

Table S1. Secondary antibodies used in this study

Table S2. Primer sets used in the quantitative real-time PCR

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer-reviewed and may be re-organized for online delivery, but are not copy-edited or typeset by Wiley-Blackwell. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

EJN_7450_sm_figureS1.tif14582KSupporting info item
EJN_7450_sm_figureS2.tif7573KSupporting info item
EJN_7450_sm_figureS3.tif2889KSupporting info item
EJN_7450_sm_tableS1.tif187KSupporting info item
EJN_7450_sm_tableS2.tif315KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.